ZIVO logo

Zivo Bioscience, Inc. Common Stock


ZIVO: Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's pipeline candidates are; Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Human Food Ingredients, and Skin Health.


Show ZIVO Financials

Consumer Interest
SEC Filings

Recent trades of ZIVO by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ZIVO's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods of modulating immune and inflammatory responses via administration of an algal biomass Jul. 20, 2021
  • Patent Title: Agents and mechanisms for treating hypercholesterolemia Nov. 24, 2020
  • Patent Title: Compounds and methods for affecting cytokines Sep. 08, 2020
  • Patent Title: Compounds and methods for affecting cytokines Mar. 19, 2019
  • Patent Title: Composition and method for affecting cytokines and nf-κb Jan. 01, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ZIVO in WallStreetBets Daily Discussion


Recent insights relating to ZIVO

CNBC Recommendations

Recent picks made for ZIVO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ZIVO

Corporate Flights

Flights by private jets registered to ZIVO